Anbio BiotechnologyNNNN
13F holders, Q1 2025 (March 31)3holders
$7.46avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Anbio Biotechnology Ltd. (NNNN) in their 13F filings. The largest holders were Marshall Wace, LLP ($325K), Geode Capital Management, LLC ($127K) and UBS Group AG ($43K).
- Company
- Anbio Biotechnology Ltd.
- CUSIP
- G0367B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $496K |
| Exits | 0 | $0 |
Ownership 3 holders
| Marshall Wace, LLP | 0.00% | New | 43,629 | $325K |
| Geode Capital Management, LLC | 0.00% | New | 17,060 | $127K |
| UBS Group AG | 0.00% | New | 5,738 | $43K |
"% of holder's portfolio" is NNNN's weight in each manager's 13F, not the share of Anbio Biotechnology Ltd. the manager owns.